Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decision Making: P-value Method01:09

Decision Making: P-value Method

5.9K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.9K
P-value01:10

P-value

7.5K
P-value is one of the most crucial concepts in statistics.
P-value stands for the probability value.  P-value is the probability that, if the null hypothesis is true, the results from another randomly selected sample will be as extreme or more extreme as the results obtained from the given sample.
A large P-value calculated from the data indicates to  not reject the null hypothesis. But a higher P-value does not mean that the null hypothesis is true. The smaller the P-value, the more...
7.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

200
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
200
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

345
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
345
Ranks01:02

Ranks

306
Unlike parametric methods, nonparametric statistics are ideal for nominal and ordinal data, requiring fewer assumptions about the population's nature or distribution. This makes nonparametric methods easier to apply and interpret, as they do not depend on parameters like mean or standard deviation. One common approach in nonparametric analysis is to sort data according to a specific criterion. For instance, we might arrange weather data from hottest to coldest days in a month or rank cities...
306
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.5K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Evidence Synthesis of Adverse Events in Imbalanced Time-to-Event Data.

Journal of evidence-based medicine·2026
Same author

A novel model (SED-GNDE) integrating graph neural differential equations with selective electrodialysis process for nutrient prediction from synthetic wastewater.

Water research·2026
Same author

Trial design-aware funnel plot for publication bias assessment with noninferiority or equivalence objectives.

Journal of clinical epidemiology·2026
Same author

EFFECTIVENESS OF DISINFECTION METHODS FOR TOOTHBRUSHES: A SYSTEMATIC REVIEW AND META-ANALYSIS.

The journal of evidence-based dental practice·2026
Same author

Evaluating data extraction error by a large language model from randomised controlled trials: a large-scale empirical study.

BMJ evidence-based medicine·2026
Same author

Unpublished trials affected evidence synthesis substantially when estimating medication harms in children.

Journal of clinical epidemiology·2026

Related Experiment Video

Updated: Oct 16, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Predictive P-score for treatment ranking in Bayesian network meta-analysis.

Kristine J Rosenberger1, Rui Duan2, Yong Chen3

  • 1Department of Statistics, Florida State University, 411 OSB, 117 N Woodward Ave, Tallahassee, FL, 32306, USA.

BMC Medical Research Methodology
|October 18, 2021
PubMed
Summary

The predictive P-score, adapted for Bayesian network meta-analysis (NMA), helps rank treatments for future studies. This new score accounts for study heterogeneity, offering clinicians a clearer way to assess treatments for new patients.

Keywords:
Bayesian analysisHeterogeneityNetwork meta-analysisP-scorePredictionTreatment ranking

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.2K
Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.3K

Related Experiment Videos

Last Updated: Oct 16, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.2K
Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.3K

Area of Science:

  • Biostatistics
  • Health Services Research

Background:

  • Network meta-analysis (NMA) synthesizes evidence from multiple treatments.
  • Measures like surface under the cumulative ranking curve (SUCRA) and P-score quantify treatment rankings in NMAs.
  • Clinicians need to apply NMA evidence to future decision-making, accounting for study heterogeneity.

Purpose of the Study:

  • Introduce the predictive P-score for treatment ranking in future studies using Bayesian models.
  • Illustrate the predictive P-score's utility with two NMAs: smoking cessation and treatment-related adverse events.
  • Compare predictive P-scores with conventional frequentist and Bayesian P-scores.

Main Methods:

  • Developed a predictive P-score within a Bayesian framework for NMAs.
  • Applied the predictive P-score to two existing NMAs.
  • Calculated frequentist P-scores, Bayesian P-scores, and predictive P-scores for all treatments.

Main Results:

  • Bayesian P-scores closely matched frequentist P-scores, with minor differences due to model assumptions.
  • Predictive P-scores tended to converge towards 0.5 due to heterogeneity, differing from conventional P-scores.
  • Predictive P-scores and posterior distribution plots offered an intuitive method for clinicians to evaluate treatments for future patients.

Conclusions:

  • The predictive P-score adapts frequentist P-scores to the Bayesian framework.
  • This novel approach aids medical decision-making by providing robust treatment rankings for future studies, considering heterogeneity.